Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Sonoma Pharmaceuticals, Inc. (SNOA) had Income from Continuous Operations of $-0.93M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$3.56M |
|
$-0.93M |
|
$2.29M |
|
$1.27M |
|
$4.59M |
|
$-1.03M |
|
$0.11M |
|
$-0.92M |
|
$-0.92M |
|
$-0.93M |
|
|
Income from Continuous Operations |
$-0.93M |
$-0.93M |
|
$-0.93M |
|
$-1.03M |
|
$-1.00M |
|
1.46M |
|
1.46M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$12.38M |
|
$0.21M |
|
$1.29M |
|
$13.67M |
|
$3.70M |
|
-- |
|
$5.09M |
|
$8.80M |
|
$4.87M |
|
$4.87M |
|
$4.87M |
|
1.62M |
|
| Cash Flow Statement Financials | |
$0.01M |
|
$-0.03M |
|
$2.79M |
|
$3.13M |
|
$5.24M |
|
$2.11M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.63% |
|
-28.93% |
|
-28.93% |
|
-- |
|
-25.79% |
|
-26.04% |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.73 |
|
1.48 |
|
60.73 |
|
-19.06% |
|
-19.06% |
|
-6.79% |
|
-19.06% |
|
$3.01 |
|
$-0.02 |
|
$0.00 |
|